Communicating the Nicotine and Tobacco Risk Continuum: A Scoping Review and Framework for Future Messaging
Ying Zhang1, Katrina Saladin1, Xinyi Wang1
1Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, USA.
Introduction:
The U.S. FDA acknowledges that commercial nicotine and tobacco products (NTPs) exist along a continuum of risk (COR), yet strategies to effectively communicate this concept remain underexamined. This scoping review synthesizes peer-reviewed studies on COR messaging across NTPs to identify promising practices and research gaps.
Methods:
Following PRISMA-ScR guidelines, we searched PubMed, CINAHL, PsycINFO, and Scopus for English-language articles (2014-2024) that empirically tested comparative or modified risk messages across NTPs. Two authors independently screened and extracted data on the conceptualization, operationalization, and effectiveness of COR messaging. We used the Message Impact Framework (MIF) to categorize message effectiveness by message receptivity, precursors to behavior, and behavioral outcomes.
Results:
Of 531 articles identified, 50 met the inclusion criteria. COR messaging was conceptualized and operationalized inconsistently across studies, with most focusing on binary comparisons (e.g., e-cigarettes/snus vs. cigarettes) rather than communicating the broader COR across multiple NTPs. The operationalization of COR messaging differed in message content (e.g., specific vs. general harm, reduced exposure vs. risk), feature (e.g., audience targeting, message source, numeric information), and delivery (e.g., placement, format). COR messages generally increased the accuracy of risk perceptions of lower-risk NTPs, though effectiveness varied.
Conclusions:
This scoping review identified practical tactics and key challenges for COR messaging across NTPs, including heterogeneous design, confusion about "complete switching," and unintended "halo effects." We propose a definition of COR messaging and a framework to address the need for a standardized conceptualization and more comprehensive evaluation of its effectiveness in future research.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Stress Prevention and Stress Management Techniques IV
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

